Why Fauci Thinks Getting Johnson & Johnson COVID-19 Vaccine "Back On Track" Soon Is Crucial
White House Chief Medical Advisor Dr. Anthony Fauci believes U.S. regulators will make a quick decision to lift the pause on administering the Johnson & Johnson (NYSE: JNJ) COVID-19 vaccine and get the vaccine “back on track.” read more.....»»
Fauci hopeful on upcoming Johnson & Johnson vaccine decision: "We will get it back in some manner or form"
CDC advisors plan to meet on Friday to discuss the Johnson & Johnson vaccine that was paused after six people developed blood clots. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, in t.....»»
Will the pause of Johnson & Johnson"s Covid-19 vaccine cause Arizona employers to back off vaccine mandates?
Will employers slow their efforts to mandate the Covid-19 vaccine at a time when one vaccine is being halted amid blood clot concerns? Here's what experts in Arizona are saying......»»
Fauci defended pausing the Johnson & Johnson COVID-19 vaccine rollout, but said those who already got the shot shouldn"t worry
The US paused the vaccine rollout on Tuesday, citing an "abundance of caution" related to six cases of b.....»»
The New York Post: Fauci suggests Johnson & Johnson COVID-19 vaccine could win emergency-use authorization in just two weeks
The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, Dr. Anthony Fauci said late Friday......»»
The New York Post: Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks
The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, Dr. Anthony Fauci said late Friday......»»
100 million doses of Johnson & Johnson"s vaccine need to be checked for contamination and may need to be thrown out
The millions of Johnson & Johnson COVID-19 vaccine doses haven't been distributed to the public and are from a plagued Emergent BioSolutions facility. Employees wor.....»»
The Wall Street Journal: Emergent CEO says company made over 100 million doses of J&J vaccine, apologizes for contaminated batch
Emergent BioSolutions Inc. has made enough of a key ingredient to yield more than 100 million doses of Johnson & Johnson’s Covid-19 vaccine, and federal health regulators are evaluating whether to release the shots, Emergent’s chief executive said......»»
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
read more.....»»
Elizabeth Warren and other Democratic senators demand to know how US pharmaceutical companies plan to share vaccine technology as COVID-19 devastates India
Lawmakers on Wednesday sent letters to Johnson & Johnson, Pfizer, and Moderna to ask if the companies plan to share t.....»»
: Goldman Sachs thinks the U.K. economy will grow faster than the U.S. — here’s why
Early indications show the country is bouncing back faster than expected due to its COVID-19 vaccine rollout......»»
The CDC is investigating 2 new reports of clotting tied to the Johnson & Johnson COVID-19 vaccine
The announcement came days after the US sa.....»»
CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson doses
The CEO of Emergent BioSolutions, the government contractor that destroyed 15 million doses of Johnson & Johnson's COVID-19 vaccine, sold more than $10 million worth of his stock in the company before its share prices plummeted......»»
The US is resuming its rollout of Johnson & Johnson"s vaccine after a pause to investigate blood clots
The COVID-19 shot will now come with a warn.....»»
: CDC committee votes to lift pause on Johnson & Johnson COVID-19 vaccine
A Centers for Disease Control and Prevention committee voted to let Americans once again receive Johnson & Johnson's single-shot COVID-19 vaccine without any additional stipulations......»»
Johnson & Johnson COVID-19 vaccine pause to be reviewed, WSJ reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
10 Things in Politics: DOJ treads lightly on Trump
And a preview of the meeting that will decide the future of the Johnson & Johnson vaccine. Donald Trump. Oliver Contreras/Getty Images Good morning! Welcome back to 10 Things in Pol.....»»
: J&J resumes European COVID-19 vaccine rollout with regulator-mandated safety warning
The European Medicines Agency demanded that a “warning about unusual blood clots with low blood platelets” be included in the product information of the Johnson & Johnson COVID-19 shots......»»
FDA report finds significant problems at Baltimore plant that contaminated Johnson & Johnson COVID vaccine
Released Wednesday, the new documents shed l.....»»
FDA inspection of Emergent"s COVID-19 vaccine plant identifies "potential quality issues"
Shares of Emergent BioSolutions Inc. were up 1.3% in trading on Wednesday after the Food and Drug Administration said it inspected a plant in Baltimore that had been scheduled to begin producing Johnson & Johnson's COVID-19.....»»
Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The Label
Johnson & Johnson (NYSE: JNJ) said Tuesday that the European rollout of its COVID-19 vaccine is set to continue after it got the go-ahead from the regulator on the continent. read more.....»»